Should we avoid protease inhibitors in first lines due to their lipid side effects? - cons
Crossref DOI link: https://doi.org/10.1186/1471-2334-14-S2-S12
Published Online: 2014-05-23
Published Print: 2014-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stellbrink, Hans-Jürgen
Article History
First Online: 23 May 2014